Janusz Piekarski
Overview
Explore the profile of Janusz Piekarski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lesiak A, Wodz K, Ceryn J, Sobolewska-Sztychny D, Bednarski I, Piekarski J, et al.
Front Med (Lausanne)
. 2025 Jan;
11():1483208.
PMID: 39839625
Introduction: Inflammasomes NLRP1 (NLR family pyrin domain containing 1) and NLRP3 are pivotal regulators of the innate immune response, activated by a spectrum of endogenous and exogenous stressors, including ultraviolet...
2.
Kowalczyk T, Piekarski J, Merecz-Sadowska A, Muskala M, Sitarek P
Biomed Pharmacother
. 2024 Sep;
180:117479.
PMID: 39326106
Isorhapontigenin (ISO), a naturally-occurring stilbene derivative, has garnered significant attention due to its potent anticancer and anti-inflammatory properties. This review synthesizes current knowledge regarding the mechanisms of action, efficacy, and...
3.
Dzikowiec M, Galant S, Lik P, Goralska K, Nejc D, Piekarski J, et al.
Adv Med Sci
. 2024 Sep;
69(2):443-450.
PMID: 39305951
Purpose: Many types of cancer have infectious origins. Gastric cancer patients can demonstrate high seroprevalence of Helicobacter pylori (H. pylori). The aim of the present study was to assess the...
4.
Jimenez-Gonzalez V, Kowalczyk T, Piekarski J, Szemraj J, Rijo P, Sitarek P
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201542
The number of cancer cases will reach 24 million in 2040, according to the International Agency for Research on Cancer. Current treatments for cancer are not effective and selective for...
5.
Kowalczyk T, Merecz-Sadowska A, Ghorbanpour M, Szemraj J, Piekarski J, Bijak M, et al.
Int J Mol Sci
. 2023 Oct;
24(20).
PMID: 37894959
The Lamiaceae is one of the most important families in the production of essential oils known to have a wide spectrum of biological activity. Recent research has highlighted the dermatological...
6.
Drzewiecka M, Gajos-Michniewicz A, Hoser G, Jasniak D, Barszczewska-Pietraszek G, Sitarek P, et al.
Genes (Basel)
. 2023 Jun;
14(6).
PMID: 37372475
The inhibition of histone deacetylases (HDACs) holds promise as a potential anti-cancer therapy as histone and non-histone protein acetylation is frequently disrupted in cancer, leading to cancer initiation and progression....
7.
Zietek M, Teterycz P, Wierzbicki J, Jankowski M, Las-Jankowska M, Zegarski W, et al.
Cancers (Basel)
. 2023 Jun;
15(10).
PMID: 37345002
Background: In melanoma treatment, an approach following positive sentinel lymph node biopsy (SLNB) has been recently deescalated from completion lymph node dissection (CLND) to active surveillance based on phase III...
8.
Pluta P, Jesionek-Kupnicka D, Pluta A, Brzozowski K, Braun M, Kubicka-Wolkowska J, et al.
Arch Med Sci
. 2023 Apr;
19(2):343-354.
PMID: 37034529
Introduction: Neoadjuvant treatment in locally advanced breast cancer (LABC) is intended to decrease the cancer mass, increase the likelihood of radical resection and improve survival. Resistance to chemotherapy may depend...
9.
Dzikowiec M, Lik P, Kiszalkiewicz J, Kuczynska A, Mordalski M, Nejc D, et al.
Pol J Microbiol
. 2022 May;
71(1):123-129.
PMID: 35635161
The infectious agents may be the etiological factor of up to 15-20% of cancers. In stomach cancer, attention is paid to and Epstein-Barr virus, both of which cause gastritis and...
10.
Kowalczyk T, Merecz-Sadowska A, Rijo P, Mori M, Hatziantoniou S, Gorski K, et al.
Cancers (Basel)
. 2022 Mar;
14(6).
PMID: 35326606
Many of the anticancer agents that are currently in use demonstrate severe side effects and encounter increasing resistance from the target cancer cells. Thus, despite significant advances in cancer therapy...